1SXP SCHOTT Pharma AG & Co. KGaA

XETRA · DE · Healthcare · Medical Instruments & Supplies · schott-pharma.com

24.70EUR+0.61%Mkt Cap: 4.04B $P/E: 27.44Today

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a g…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap4.04B USD

Enterprise Value4.30B USD

Revenue (TTM)1.11B USD

Gross Profit361.37M USD

Net Income (TTM)159.19M USD

Revenue/Share6.73 EUR

Last Price24.70 EUR

Fiscal Year EndSep 2025

MR QuarterJun 2026

Employees5.0K

CountryDE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINDE000A3ENQ51

Valuation

P/E (Trailing)27.44

P/E (Forward)22.42

PEG—

EV/EBITDA15.85

EV/Revenue3.89

P/S3.64

P/B3.68

EPS (TTM)0.90

EPS (Forward)1.10

52W Range

12.6293% of range25.60

52W High25.60 EUR

52W Low12.62 EUR

Profitability

Gross Margin33.71%

Oper. Margin17.36%

EBITDA Margin24.52%

Profit Margin14.85%

ROE16.42%

ROA9.16%

Growth

Revenue Growth10.00%

Earnings Growth-13.30%

Cash Flow & Leverage

Operating CF195.57M USD

CapEx (TTM)157.34M USD

FCF Margin-1.94%

FCF Yield-0.53%

Net Debt308.02M USD

Net Debt/EBITDA1.14

Balance Sheet

Debt/Equity0.09

Current Ratio1.61

Quick Ratio0.74

Book Value/Sh6.67 EUR

Cash/Share0.17 EUR

Dividends

Fwd Div Rate0.18 EUR

Trail. Div Rate0.18 EUR

Div. Yield0.73%

5Y Avg Yield—

Payout Ratio20.00%

Ex-Div DateFeb 4, 2026

Pay Date—

Analyst Consensus

Rating—

Target (Mean)23.68 EUR

Upside (mean)-4.1%

Target Range13.00 EUR – 27.10 EUR

13.00-4.1% to mean27.10

# Analysts13

Ownership

Shares Out.150.61M

Float34.35M

Insiders77.00%

Institutions19.94%

Technical

SMA 5022.98 (+7.5%)

SMA 20017.55 (+40.8%)

Beta0.99

S&P 52W Chg14.58%

Avg Vol (30d)64.92K

Avg Vol (10d)71.65K

Technical Indicators

RSI (14)61.4

MACD0.5601

MACD Signal0.5248

MACD Hist.+0.0353

BB Upper25.29 EUR

BB Middle23.78 EUR

BB Lower22.28 EUR

BB Width12.65%

ATR (14)0.6410 EUR

Vol Ratio (20d)0.92x